CoChat

Prognostic impact of myosteatosis in patients with colorectal cancer: a systematic review and meta‐analysis

Lee, Chan Mi, Kang, Jeonghyun · 2020 · Journal of Cachexia, Sarcopenia and Muscle
Cited by 128

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Abstract

Background: Myosteatosis has been reported to be a novel biomarker that could predict survival outcomes in patients with colorectal cancer. However, results have been conflicting. This systematic review and meta‐analysis aimed to evaluate the long‐term impact of myosteatosis on the survival of these patients. Methods: A systematic search of PubMed, Embase, and Cochrane up to 27 November 2019 generated 7022 records. Studies that reported hazard ratio (HR) for overall survival, cancer‐specific survival, or disease‐free survival based on myosteatosis or radiodensity were included. A total of 110 full‐text articles were considered for inclusion, and 14 were selected for qualitative analysis. Inverse variance method was used with random effects model for data analysis. Results: The total number of enrolled patients included in the meta‐analysis was 6518 for univariate and 8572 for multivariate HR analysis, from 12 and 10 studies, respectively. Patients with myosteatosis had a significant increase in overall mortality compared with non‐myosteatosis patients by both univariate analysis [HR 1.38, 95% confidence interval (CI) 1.21 to 1.58, P < 0.00001] and multivariate analysis (HR 1.55, 95% CI 1.23 to 1.96, P < 0.00001). In subgroup analysis based on studies that reported HRs of both sarcopenia and myosteatosis, the negative effect of myosteatosis on overall survival was independent of sarcopenia using univariate values (sarcopenia HR 1.48, 95% CI 1.14 to 1.91, P = 0.003 vs. myosteatosis HR 1.51, 95% CI 1.17 to 1.96, P = 0.002) and multivariate values (sarcopenia HR 1.28, 95% CI 1.09 to 1.49, P = 0.002 vs. myosteatosis HR 1.38, 95% CI 1.07 to 1.80, P = 0.001). Conclusions: This meta‐analysis demonstrates that myosteatosis is associated with worse overall survival in patients with colorectal cancer. More investigation is needed to standardize the measurement protocol for myosteatosis and to further optimize its prognostic power for colorectal cancer patients.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/jcsm.12575

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Research works printed but not linked: 41

  1. 10.1038/s41598-017-16955-5 · DOI · Paper page
  2. 10.1016/j.critrevonc.2017.06.002 · DOI · Paper page
  3. 10.1016/j.clnu.2017.05.017 · DOI · Paper page
  4. 10.1002/jcsm.12379 · DOI · Paper page
  5. 10.1016/j.ejca.2015.12.030 · DOI · Paper page
  6. 10.1097/SLA.0000000000002679 · DOI · Paper page
  7. 10.1002/bjs.10075 · DOI · Paper page
  8. 10.1002/cncr.31405 · DOI · Paper page
  9. 10.1002/jcsm.12301 · DOI · Paper page
  10. 10.1200/JCO.2012.45.2722 · DOI · Paper page
  11. 10.1097/DCR.0000000000000958 · DOI
  12. 10.1016/j.critrevonc.2019.102839 · DOI · Paper page
  13. 10.1002/jpen.1171 · DOI
  14. 10.1371/journal.pmed.1000097 · DOI · Paper page
  15. 10.2307/2529310 · DOI · Paper page
  16. 10.1002/jcsm.12357 · DOI · Paper page
  17. 10.1016/0197-2456(86)90046-2 · DOI · Paper page
  18. 10.1136/bmj.327.7414.557 · DOI · Paper page
  19. 10.1111/j.0006-341X.2000.00455.x · DOI · Paper page
  20. WellsGA TugwellP O'ConnellD WelchV PetersonJ SheaB &Losos M.The Newcastle–Ottawa scale (NOS) for assessing the quality of nonrandomised studies in meta‐analyses http://www.Ohri.ca/Programs/Clinical_epidemiology/Oxford.Asp(2001).https://ci.nii.ac.jp/naid/20000796643/(accessed August 11 2019).
  21. 10.1186/2046-4053-3-82 · DOI · Paper page
  22. 10.1200/JCO.2015.63.6043 · DOI · Paper page
  23. 10.1007/s00432-018-2736-z · DOI
  24. 10.1016/j.ejso.2018.05.029 · DOI
  25. 10.1186/s12885-019-5319-8 · DOI
  26. 10.1097/DCR.0000000000001352 · DOI
  27. 10.2214/AJR.17.18020 · DOI · Paper page
  28. Looijaard SMLM, 2019, Computed tomography-based body composition is not consistently associated with outcome in older patients with colorectal cancer, Oncologist, 25, 1
  29. 10.1002/jso.23366 · DOI
  30. 10.1016/j.clnesp.2019.04.004 · DOI
  31. 10.1017/S0029665118000423 · DOI · Paper page
  32. 10.1093/ejcts/ezy291 · DOI
  33. 10.1002/jcsm.12234 · DOI · Paper page
  34. 10.1016/j.clnu.2019.03.014 · DOI
  35. 10.1001/jamaoncol.2017.2319 · DOI · Paper page
  36. 10.1007/s41999-018-0110-y · DOI
  37. 10.1038/sj.bjc.6603446 · DOI
  38. 10.21037/tgh.2018.07.11 · doi:10.21037/tgh.2018.07.11
  39. 10.1016/j.clnu.2017.07.007 · DOI
  40. 10.4161/adip.28546 · DOI · Paper page
  41. 10.1002/jcsm.12501 · DOI · Paper page

Cited by

See all 128

Metadata

Authors
Lee, C. M., & Kang, J.
Affiliations
  • Cleveland Clinic Lerner College of Medicine of Case Western Reserve University Cleveland OH USA
  • Department of Surgery Gangnam Severance Hospital, Yonsei University College of Medicine Gangnam‐gu Seoul Korea
Venue
Journal of Cachexia, Sarcopenia and Muscle
Publisher
Wiley
Published
2020-06
Volume
11
Issue
5
Pages
1270-1282
ISSN
  • 2190-5991
  • 2190-6009
Cited by
128
References
7
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Prognostic impact of myosteatosis in patients with colorectal cancer: a systematic review and meta‐analysis. https://app.cochat.ai/papers/10.1002/jcsm.12575
The paper
Lee, C. M., & Kang, J. (2020). Prognostic impact of myosteatosis in patients with colorectal cancer: a systematic review and meta‐analysis. Journal of Cachexia, Sarcopenia and Muscle. https://doi.org/10.1002/jcsm.12575

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.